Skip to main navigation

Back

Contact Revance
Login

Menu

Aesthetics
Back Aesthetics
Visit Site
Therapeutics
Back Therapeutics
Investors
Back Investors
LATEST NEWS
In the News

April 27, 2021

Experts Call These the Most Cutting-Edge Aesthetic Treatments

InStyle

All News
Company
Back Company
OUR LATEST
In the News

April 27, 2021

Experts Call These the Most Cutting-Edge Aesthetic Treatments

InStyle

Our Latest
News
Careers
Back Careers

facebook
instagram
twitter
linkedin

1222 Demonbreun St
20th Floor
Nashville, TN 37203

Contact Revance
Login

© Copyright 2022

All Rights Reserved

Breadcrumb

Home
Investors
Press releases

Press Releases

Press Releases

Items Per Page

Year

February 22, 2021

Revance Appoints Biotech and Pharmaceutical Executive, Olivia C. Ware, and Fintech and Payments Thought Leader and Entrepreneur, Carey O’Connor Kolaja, to its Board of Directors

February 12, 2021

Revance to Release Fourth Quarter and Full Year 2020 Financial Results on Monday, February 22, 2021

January 25, 2021

Revance to Highlight Aesthetic Clinical Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Filler Study Results at Maui Derm for Dermatologists 2021

January 22, 2021

Revance Issues Inaugural Environmental, Social and Governance (ESG) Report

January 19, 2021

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

January 7, 2021

Revance to Participate in the 39th Annual J.P. Morgan Healthcare Conference

January 7, 2021

Revance Provides Corporate Update and Anticipated Milestones for 2021

December 22, 2020

Ajinomoto Bio-Pharma Services and Revance Therapeutics Announce Manufacturing Agreement for Supply of DaxibotulinumtoxinA for Injection

December 21, 2020

Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 17, 2020

Revance Reports Positive Efficacy and Duration Results from Phase 2 Upper Facial Lines Study

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 31 - 40 of 268

Investor Relations

Investor Relations
Press Releases
Events & Presentations
- Events
- Presentations and Corporate Materials
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQs
Contact Us

image description

Revance - Shareholder Tools

Print Page
Printed Materials
Email Alerts
Download Library
RSS News Feeds
Share
Search

Keep up with Revance

Subscribe

1222 Demonbreun St
20th Floor
Nashville, TN 37203

facebook
instagram
twitter
linkedin

Aesthetics

Overview
RHA®
OPUL
Neuromodulator
Neuromodulator Uses
Clinical Highlights

Therapeutics

Overview
Cervical Dystonia
Upper Limb Spasticity
Plantar Fasciitis
Clinical Highlights

Investors

Investor Relations
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
Stock Information
Analyst Coverage
Investor FAQ
Contact Us

Company

Overview
About Revance
Leadership Team
Board of Directors
Partnerships
Investigator Sponsored Trials
Medical Education Grants
Sustainability
Contact Revance

News

All News
In the News
Our Latest

Careers

Overview
Career Opportunities
Culture
Benefits & Perks
Privacy Notice

© Copyright 2022
All Rights Reserved
Terms of Use
Privacy Policy
Corporate Social Media Community Guidelines

Facebook
LinkedIn